| Characterization of hypermutator Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Australia VE Rees, DS Deveson Lucas, C López-Causapé, Y Huang, T Kotsimbos, ... Antimicrobial Agents and Chemotherapy 63 (4), 10.1128/aac. 02538-18, 2019 | 55 | 2019 |
| Optimization of a meropenem-tobramycin combination dosage regimen against hypermutable and nonhypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow … CB Landersdorfer, VE Rees, R Yadav, KE Rogers, TH Kim, PJ Bergen, ... Antimicrobial Agents and Chemotherapy 62 (4), 10.1128/aac. 02055-17, 2018 | 35 | 2018 |
| Meropenem combined with ciprofloxacin combats hypermutable Pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients VE Rees, R Yadav, KE Rogers, JB Bulitta, V Wirth, A Oliver, JD Boyce, ... Antimicrobial agents and chemotherapy 62 (11), 10.1128/aac. 01150-18, 2018 | 33 | 2018 |
| Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa VE Rees, JB Bulitta, A Oliver, BT Tsuji, CR Rayner, RL Nation, ... Journal of Antimicrobial Chemotherapy 71 (11), 3157-3167, 2016 | 30 | 2016 |
| Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa VE Rees, JB Bulitta, RL Nation, BT Tsuji, F Sörgel, CB Landersdorfer Journal of Antimicrobial Chemotherapy 70 (3), 818-826, 2015 | 24 | 2015 |
| Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract KA Hedin, VE Rees, H Zhang, V Kruse, R Vazquez-Uribe, MOA Sommer Scientific Reports 12 (1), 8862, 2022 | 17 | 2022 |
| Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae M Hussein, LJM Wong, J Zhao, VE Rees, R Allobawi, R Sharma, GG Rao, ... Computational and Structural Biotechnology Journal 20, 1077-1087, 2022 | 11 | 2022 |
| Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling VE Rees, JB Bulitta, A Oliver, RL Nation, CB Landersdorfer Pharmaceutics 11 (9), 470, 2019 | 7 | 2019 |
| Cold exposure and oral delivery of GLP-1R agonists by an engineered probiotic yeast strain have antiobesity effects in mice KA Hedin, H Zhang, V Kruse, VE Rees, F Backhed, TU Greiner, ... ACS Synthetic Biology 12 (11), 3433-3442, 2023 | 3 | 2023 |
| Oral delivery of GLP-1R agonist by an engineered probiotic yeast strain has anti-obesity effects in mice KA Hedin, H Zhang, V Kruse, VE Rees, F Bäckhed, TU Greiner, ... bioRxiv, 2022.12. 21.521368, 2022 | 1 | 2022 |
| Fighting resistant bacterial'superbugs' by novel antibiotic combination dosing strategies VE REES Monash University, 0 | | |
| Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia-DTU Orbit (19/08/2019) VE Rees, DS Deveson Lucas, C López-Causapé, Y Huang, T Kotsimbos, ... | | |
| Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia-DTU Orbit (21/08/2019) VE Rees, DS Deveson Lucas, C López-Causapé, Y Huang, T Kotsimbos, ... | | |
Jurgen BulittaUniversity of Florida在 bulitta.com 的电子邮件经过验证
